0% Complete
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
HLA Class I Alleles as prognostic marker in Hepatocellular Carcinoma
نویسندگان :
Shahram Aliyari
1
Zahra Salehi
2
Mohammad Hossein Norouzi-Beirami
3
Kaveh Kavousi
4
1- Department of Bioinformatics, Kish International Campus University of Tehran, Kish, Iran. 2 Institute of Biochemistry and Biophysics (IBB), Department of Bioinformatics, Laboratory of Complex Biological
2- Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Tehran, Iran
3- Department of Computer Engineering, Osku Branch, Islamic Azad University, Osku, Iran
4- 2 Institute of Biochemistry and Biophysics (IBB), Department of Bioinformatics, Laboratory of Complex Biological Systems and Bioinformatics (CBB), University of Tehran, Tehran, Iran.
کلمات کلیدی :
Hepatocellular carcinoma،Human Leukocyte Antigen،Prognostic factors،Bioinformatics
چکیده :
Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide, accounting for a significant portion of cancer-related deaths. Its aggressive nature, late diagnosis, and resistance to conventional therapies contribute to poor clinical outcomes. Immune evasion, a hallmark of cancer progression, plays a pivotal role in HCC, allowing tumor cells to escape immune surveillance and establish a favorable microenvironment for growth and metastasis. Human Leukocyte Antigen (HLA) Class I molecules are critical components of the immune system that mediate tumor-immune interactions by presenting tumor-derived antigens to cytotoxic T lymphocytes (CTLs). Disruptions in HLA expression or allele-specific variations can impair antigen presentation, reducing immune recognition and facilitating tumor immune escape. Despite this central role, the specific impact of HLA Class I alleles on HCC progression, prognosis, and therapeutic response remains underexplored. A deeper understanding of the relationship between HLA-I alleles and HCC could reveal novel immunogenomic biomarkers for both prognosis and therapeutic intervention. To address this knowledge gap, we conducted a comprehensive analysis of HLA Class I alleles in HCC patients using data from The Cancer Genome Atlas (TCGA). Our dataset comprised 8,998 samples, including patients with HCC and a pan-cancer cohort. We investigated allele frequency disparities across these groups to identify HLA-I alleles with potential prognostic significance. Statistical analyses were performed using Fisher's exact test to determine the significance of allele frequency differences, providing insights into their association with HCC development and clinical outcomes. Several HLA Class I alleles were identified as significantly associated with an increased risk of HCC, including A11:01, A33:03, B46:01, C01:02, C07:06, and C08:01. These alleles demonstrated higher frequencies in HCC patients compared to the pan-cancer cohort, suggesting their role in disease susceptibility. Notably, HLA-B*51:01 exhibited a significant correlation with improved survival outcomes (Log HR -0.769, p-value 0.035), highlighting its potential as a prognostic biomarker. However, the prognostic relevance of other identified alleles remains unclear and requires further validation through detailed survival analyses. This study highlights the importance of HLA Class I alleles in HCC, revealing their association with disease risk and survival outcomes. These findings suggest that specific HLA-I alleles may serve as valuable immunogenomic biomarkers for prognosis, paving the way for tailored therapeutic strategies, including personalized immunotherapy approaches. Future studies are warranted to further elucidate the functional mechanisms underlying these associations and their clinical utility. Keywords: Hepatocellular carcinoma, Human Leukocyte Antigen, Prognostic factors, Bioinformatics
لیست مقالات
لیست مقالات بایگانی شده
Element-Specific Estimation of Background Mutation Rates in Whole Cancer Genomes Through Transfer Learning
ّFarideh Bahari - Reza Ahangari Cohan - Hesam Montazeri
Molecular Docking Study of Pyrazole Interaction with Bovine Serum Albumin (BSA): Insights from Drug-Protein Binding
Parisa Zallou - Yaghub Pazhang - Ebrahim Nemati-Kande
Innovative Multi-Epitope Vaccine for Breast Cancer Management: Utilizing MAGE-A, MAM-A, and Gal-3 through an In Silico Reverse Vaccinology Approach
Faranak Aali - Abbas Doosti - Mostafa Shakhsi-Niaei
Expansion and Sequencing of the DNA Code Used in the COVID-19 Vaccine Using Meta-Heuristic Algorithms
Ahmad Aliyari Boroujeni - Mohammadreza Parsayi - Hossein Rahmati
A Fuzzy Bayesian Network Model for Personalized Diabetes Risk Prediction: Integrating Lifestyle, Genetic, and Environmental Factors
Lida Hooshyar - Nadia Tahiri
A New Method in Analyzing Drug-Drug Interaction Using Artificial Intelligence: Combination of Channel and Spatial Maps in Deep Attention Networks
Seyed Vahab Shojaedini - AmirReza Moeini
Encoding the gRNA-DNA Pairs with Deep Transformers to Predict off-target Effects of CRISPR
Roghayyeh Alipanahi - Leila Safari - Alireza Khanteymoori
Identification of key genes associated with glioblastoma multiforme using microarray data
Motahareh Shanyan - Sohrab Boozarpour - Zahra Pezeshkian - Hossain Sabori - Mahmoud Salehi
Fully Convolutional Neural Networks for Volumetric Segmentation of Ultrasound Images: An Effective Tool for Automated Estimation of Fetal Head Circumference
Seyed Vahab Shojaedini - Mohammad Momenian
Dissecting the genetic causes of inflammatory bowel disease based on whole exome sequencing
Amir Shahbazi - Mehdi Totonchi
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.7.0